Pr François Ghiringhelli
- Spécialité
- Oncologue médical, expert digestif
- Hôpital
- Centre Georges-François Leclerc (Dijon)
- Derniers articles
-
- NIR-II aza-BODIPY Platform for the Development of a Fluorescent Antibody Drug Conjugate. (28 mars 2025)
- Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies. (6 mars 2025)
- FOLFIRINOX-3 plus bevacizumab (bFOLFIRINOX3) in chemo-refractory metastatic colorectal cancer: a multicenter phase II trial. (1 mars 2025)
- Mimicry-based strategy between human and commensal antigens for the development of a new family of immune therapies for cancer. (20 févr. 2025)
- Deep learning uncovers histological patterns of YAP1/TEAD activity related to disease aggressiveness in cancer patients. (20 déc. 2024)